PhlebX
Closing the Last-Mile Gap in Diagnostic Care

For many patients, getting routine blood work has always meant rearranging schedules, driving across town, and sitting in crowded waiting rooms. For elderly individuals, homebound patients, and those living with chronic illnesses, these hurdles often create far more than inconvenience; they lead to missed tests, delayed diagnoses, and poorer health outcomes.

PhlebX was built to remove those barriers entirely.

As a mobile phlebotomy provider powered by a fully digital, cloud-based platform, the company brings the lab to the patient, delivering efficiency, accuracy, and compassionate care where it is needed most.

From its earliest days, PhlebX recognized that the last mile of diagnostic testing, the simple act of getting blood drawn, was often the most difficult. The company designed its proprietary technology platform to bridge that gap. Laboratories and physicians integrate directly with the system, which receives orders electronically and dispatches phlebotomists through the PhlebX mobile app. This streamlined workflow connects all stakeholders in a single, secure digital environment.

“Our unique solution enables a fully digital workflow by connecting labs and physicians via our cloud-based platform and dispatching phlebotomists to patients in their designated geographic area,” says Yary Mordkovich, chief operating officer.

Security sits at the core of this technology. The platform is ISO 27001 certified, uses encrypted data transfers, and masks personal identifiers. Phlebotomists must log in repeatedly as the app times out within seconds, ensuring data protection even in the field. This level of rigor is a departure from the industry’s traditional paper-based practices, which often created delays and introduced human error. PhlebX equips every phlebotomist with a mobile Zebra printer that generates accurate, scannable labels at the point of collection, allowing many specimens to reach the lab nearly preaccessioned. What once required multiple manual steps now moves through the system with remarkable efficiency.

The company’s model has been particularly transformative for rural and underserved communities. Healthcare systems working with PhlebX often supply heat maps of patient distribution, allowing the company to strategically staff phlebotomists across wide geographic areas. Assignments are automatically routed based on zip codes, ensuring fast response times. In many regions, patients receive a call from PhlebX within twenty-four hours of an order and can expect a home visit within forty-eight hours. This level of access significantly increases adherence to diagnostic protocols, giving physicians reliable data to guide care.

The impact extends well beyond convenience. For vulnerable groups, especially patients managing cancer treatments, the PhlebX model can prevent unnecessary suffering. Many individuals undergoing chemotherapy are already immunocompromised and fatigued. Without home-based draws, they often travel long distances only to discover upon arrival that their bloodwork disqualifies them from receiving treatment that day. By collecting specimens beforehand, PhlebX helps avoid these wasted trips and supports safer, more predictable care.

Internally, the company has built a culture that blends technological precision with human empathy. Its phlebotomists prefer working outside brick-and-mortar clinics, enjoying both the flexibility and the opportunity to meet patients in their own environments. The app, designed to replace cumbersome paperwork, guides them through visit protocols and enforces regulatory compliance. The result is a workforce that feels supported, connected, and empowered to deliver exceptional service.

The company’s commitment to increasing diagnostic access is also supported by data. A recent industry study shows that 36 percent of chronic disease patients and 33 percent of individuals with mobility challenges do not adhere to testing protocols because of transportation limitations or cost barriers.

By eliminating these barriers, PhlebX aims to drive those percentages into the single digits for everyone’s benefit.